GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (HAM:MAH0) » Definitions » Price-to-Tangible-Book

Mereo BioPharma Group (HAM:MAH0) Price-to-Tangible-Book : 10.96 (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mereo BioPharma Group Price-to-Tangible-Book?

As of today (2024-06-23), Mereo BioPharma Group's share price is €3.55. Mereo BioPharma Group's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.32. Hence, Mereo BioPharma Group's Price to Tangible Book Ratio of today is 10.96.

The historical rank and industry rank for Mereo BioPharma Group's Price-to-Tangible-Book or its related term are showing as below:

HAM:MAH0' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.81   Med: 2.21   Max: 10.76
Current: 10.76

During the past 9 years, Mereo BioPharma Group's highest Price to Tangible Book Ratio was 10.76. The lowest was 1.81. And the median was 2.21.

HAM:MAH0's Price-to-Tangible-Book is ranked worse than
89.83% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs HAM:MAH0: 10.76

A closely related ratio is called PB Ratio. As of today, Mereo BioPharma Group's share price is €3.55. Mereo BioPharma Group's Book Value per Sharefor the quarter that ended in Dec. 2023 was €0.33. Hence, Mereo BioPharma Group's P/B Ratio of today is 10.73.


Mereo BioPharma Group Price-to-Tangible-Book Historical Data

The historical data trend for Mereo BioPharma Group's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Price-to-Tangible-Book Chart

Mereo BioPharma Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only - - - - -

Mereo BioPharma Group Quarterly Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mereo BioPharma Group's Price-to-Tangible-Book

For the Biotechnology subindustry, Mereo BioPharma Group's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mereo BioPharma Group's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's Price-to-Tangible-Book falls into.



Mereo BioPharma Group Price-to-Tangible-Book Calculation

Mereo BioPharma Group's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=3.55/0.324
=10.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Mereo BioPharma Group Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Mereo BioPharma Group (HAM:MAH0) Business Description

Comparable Companies
Traded in Other Exchanges
Address
One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Mereo BioPharma Group (HAM:MAH0) Headlines

No Headlines